ARMISTICE CAPITAL, LLC

Q3 2022 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
197
Total value ($000)
$5,764,927
Net value change ($000)
+32,708 (0.6%)
New positions
64
Sold out positions
53
Turnover %
82.6%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/15/2022 Next filing: 2/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
GSK 105,948 NEW
FRPT 95,534 230.1%
ROST 83,530 593.9%
FIVE 76,163 NEW
AGIO 54,411 NEW
EXAS 50,684 NEW
PCRX 50,164 145.3%
TGT 44,664 NEW
DECK 39,632 NEW
OGN 39,593 NEW
Top Reduces (Value $000, Stocks/ETFs)
SPY -1,263,788 -100.0%
IWM -567,356 -100.0%
DG -75,631 -100.0%
CPRX -71,502 -100.0%
ILMN -62,498 -100.0%
AZN -55,235 -100.0%
TSCO -51,802 -100.0%
BMY -46,358 -52.1%
VRTX -44,487 -50.6%
JAZZ -43,371 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,790,265 (31.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None